“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine. The article explores the history of nanotechnology, its current application and Dr. Stayton’s current work developing a nanotechnology delivery system to treat certain diseases, including liver cancer.
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine
Folch lab and collaborators examine how cells use systems-level mechanisms to process information in new PNAS paper
UW Bioengineering associate professor Albert Folch, Folch lab senior fellow Nirveek Bhattacharjee and collaborators at Fred Hutchinson Cancer Research Center and the University of Buenos Aires in Argentina have published research in the early online edition of the Proceedings of the National Academy of Sciences (PNAS) examining how cells use systems-level mechanisms to process environmental information. The research shows a promising example of how microfluidics can be used to expose cells to complex signals, a major goal in systems biology studies.
Anti-HIV materials being developed by the Woodrow group could be integrated into a dissolvable, “tampon”-like product that is both easy for women to use and also effective, reports the Huffington Post.
UW Bioengineering Assistant Professor Dr. Kim Woodrow led a Bill and Melinda Gates Foundation youth educational outreach event on July 23, which exposed 6th to 8th graders to a college campus and laboratory and led participants in inquiry-based learning activities about STEM applications for pediatric HIV.
Bioengineers in Dr. Woodrow’s lab have discovered a faster way to deliver a topical drug that can protect women from contracting HIV. The researchers created a fiber material embedded with the drug through a process called electrospinning that quickly dissolves and releases a potent antiretroviral drug, maraviroc, when it comes into contact with moisture.
UW Bioengineering Summer Camp 2014 concludes, teaches high school students about bioengineering, global health
UW Bioengineering Summer Camp 2014 wraps up, teaching 24 high school students about the field of bioengineering and and the field’s solutions for global health problems.
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).
UW Bioengineering faculty Charles Murry (joint professor of pathology, bioengineering and medicine/cardiology) and Michael Regnier, as well as adjunct faculty Michael Jensen, MD, director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute and professor of pediatric hematology-oncology at UW Medicine and Satoshi Minoshima, professor of radiology, were named 2014 UW Presidential Entrepreneurial Faculty Fellows.
Class of 2014 celebrates, David C. Auth delivers keynote speech, at Bioengineering Departmental Graduation Ceremony
The UW Bioengineering Class of 2014 celebrated their impressive accomplishments, David C. Auth delivered keynote speech, at the 2014 Bioengineering Departmental Graduation Ceremony.
In this issue: Chair’s Letter – Note to Graduates – Features – News Briefs – In the Media – Events Dear Alumni and Friends, With a sense of pride, we […]